Ziv-aflibercept Efficacy in Better Regulating AMD

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

July 7, 2017

Primary Completion Date

June 26, 2020

Study Completion Date

June 26, 2020

Conditions

Wet Macular DegenerationWet Age-related Macular Degeneration

Interventions

DRUG

Ziv-Aflibercept 25 MG/ML [Zaltrap]

Anti-VEGF injection

DRUG

Ranibizumab

Anti-VEGF standard of care injection

Trial Locations (1)

Wagner Macula & Retina Center, Virginia Beach

All Listed Sponsors

lead

Kapil Kapoor

OTHER

NCT03423823 - Ziv-aflibercept Efficacy in Better Regulating AMD | Biotech Hunter | Biotech Hunter